Please assess the completion status of the following clinical trial:

Trial Title: Effects of a Dopamine Agonist on Pharmacodynamics of Levodopa in Parkinson's Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE1
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Age 30-80~* Idiopathic PD Hoehn \& Yahr stage 2-4,~* diagnosed by 2 of the 3 cardinal motor features~* Fluctuation response to levodopa~* Dyskinesia~* No other historical, laboratory or physical signs to suggest an alternate diagnosis~* No significant dementia, MMSE\>24~* On oral levodopa therapy~Exclusion Criteria:~* dementia~* psychosis~* severe anxiety~* unstable cardiovascular disease~* uncontrolled hypertension~* history of cardiac arrhythmias~* active peptic ulcer disease~* anemia (HCT\<32%)

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).